The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India

Purpose: Phase IV clinical studies are usually performed after a new drug obtains approval from a regulatory agency for marketing and use in the general population. There is not much information available on public platform regarding the types of contemporary Phase IV studies conducted in India. We...

Full description

Saved in:
Bibliographic Details
Main Authors: Bikash Ranjan Meher, Bikram Keshari Rout, Subashri Ponnusamy, Rashmi Ranjan Mohanty, Biswa Mohan Padhy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-07-01
Series:Perspectives in Clinical Research
Subjects:
Online Access:https://journals.lww.com/10.4103/picr.picr_150_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849406066142478336
author Bikash Ranjan Meher
Bikram Keshari Rout
Subashri Ponnusamy
Rashmi Ranjan Mohanty
Biswa Mohan Padhy
author_facet Bikash Ranjan Meher
Bikram Keshari Rout
Subashri Ponnusamy
Rashmi Ranjan Mohanty
Biswa Mohan Padhy
author_sort Bikash Ranjan Meher
collection DOAJ
description Purpose: Phase IV clinical studies are usually performed after a new drug obtains approval from a regulatory agency for marketing and use in the general population. There is not much information available on public platform regarding the types of contemporary Phase IV studies conducted in India. We aimed to determine the fundamental characteristics of Phase IV clinical trials using the Clinical Trials Registry–India (CTRI) registry data. Materials and Methods: A comprehensive search was undertaken for the total number of Phase IV studies registered between the inception of CTRI and May 2024. Information was analyzed based on the different characteristics of the registered study like year of registration, type of study, type of intervention, type of outcome, and type of sponsorship. Results: Two hundred and thirty-eight studies fulfilling the inclusion criteria were included in the analysis. Twenty-nine (12.2%) of those were undertaken to assess only safety outcomes, 27 (11.4%) had only efficacy outcomes whereas a large number of studies (n = 182, 76.4%) were conducted to assess both safety as well as efficacy parameters. Almost 98% of the studies did not provide details of publication on the CTRI platform. Conclusion: Although progress has been made in the conduction of clinical research in India, there is a need to conduct more Phase IV clinical studies and provide the details of their publication on the CTRI site to enhance credibility and transparency.
format Article
id doaj-art-549501f64d3240e9a2e1bf05483f49d3
institution Kabale University
issn 2229-3485
2229-5488
language English
publishDate 2025-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Perspectives in Clinical Research
spelling doaj-art-549501f64d3240e9a2e1bf05483f49d32025-08-20T03:36:31ZengWolters Kluwer Medknow PublicationsPerspectives in Clinical Research2229-34852229-54882025-07-0116313814210.4103/picr.picr_150_24The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-IndiaBikash Ranjan MeherBikram Keshari RoutSubashri PonnusamyRashmi Ranjan MohantyBiswa Mohan PadhyPurpose: Phase IV clinical studies are usually performed after a new drug obtains approval from a regulatory agency for marketing and use in the general population. There is not much information available on public platform regarding the types of contemporary Phase IV studies conducted in India. We aimed to determine the fundamental characteristics of Phase IV clinical trials using the Clinical Trials Registry–India (CTRI) registry data. Materials and Methods: A comprehensive search was undertaken for the total number of Phase IV studies registered between the inception of CTRI and May 2024. Information was analyzed based on the different characteristics of the registered study like year of registration, type of study, type of intervention, type of outcome, and type of sponsorship. Results: Two hundred and thirty-eight studies fulfilling the inclusion criteria were included in the analysis. Twenty-nine (12.2%) of those were undertaken to assess only safety outcomes, 27 (11.4%) had only efficacy outcomes whereas a large number of studies (n = 182, 76.4%) were conducted to assess both safety as well as efficacy parameters. Almost 98% of the studies did not provide details of publication on the CTRI platform. Conclusion: Although progress has been made in the conduction of clinical research in India, there is a need to conduct more Phase IV clinical studies and provide the details of their publication on the CTRI site to enhance credibility and transparency.https://journals.lww.com/10.4103/picr.picr_150_24clinical trial registryclinical trials registry-indiaphase iv clinical trialsphase iv studiespostmarketing studies
spellingShingle Bikash Ranjan Meher
Bikram Keshari Rout
Subashri Ponnusamy
Rashmi Ranjan Mohanty
Biswa Mohan Padhy
The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
Perspectives in Clinical Research
clinical trial registry
clinical trials registry-india
phase iv clinical trials
phase iv studies
postmarketing studies
title The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
title_full The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
title_fullStr The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
title_full_unstemmed The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
title_short The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
title_sort landscape of phase iv clinical trials in india a comprehensive analysis of the clinical trial registry india
topic clinical trial registry
clinical trials registry-india
phase iv clinical trials
phase iv studies
postmarketing studies
url https://journals.lww.com/10.4103/picr.picr_150_24
work_keys_str_mv AT bikashranjanmeher thelandscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT bikramkesharirout thelandscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT subashriponnusamy thelandscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT rashmiranjanmohanty thelandscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT biswamohanpadhy thelandscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT bikashranjanmeher landscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT bikramkesharirout landscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT subashriponnusamy landscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT rashmiranjanmohanty landscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia
AT biswamohanpadhy landscapeofphaseivclinicaltrialsinindiaacomprehensiveanalysisoftheclinicaltrialregistryindia